- Home
- TCRX vs GAUZ Comparison
TCRX vs GAUZ Comparison
Compare TCRX & GAUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- GAUZ
- Stock Information
- Founded
- TCRX 2018
- GAUZ 2009
- Country
- TCRX United States
- GAUZ Israel
- Employees
- TCRX N/A
- GAUZ N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- GAUZ Industrial Machinery/Components
- Sector
- TCRX Health Care
- GAUZ Miscellaneous
- Exchange
- TCRX Nasdaq
- GAUZ Nasdaq
- Market Cap
- TCRX 91.7M
- GAUZ 102.0M
- IPO Year
- TCRX 2021
- GAUZ 2024
- Fundamental
- Price
- TCRX $1.60
- GAUZ $5.87
- Analyst Decision
- TCRX Strong Buy
- GAUZ Strong Buy
- Analyst Count
- TCRX 5
- GAUZ 3
- Target Price
- TCRX $9.40
- GAUZ $13.67
- AVG Volume (30 Days)
- TCRX 219.1K
- GAUZ 55.6K
- Earning Date
- TCRX 11-11-2025
- GAUZ 11-11-2025
- Dividend Yield
- TCRX N/A
- GAUZ N/A
- EPS Growth
- TCRX N/A
- GAUZ N/A
- EPS
- TCRX N/A
- GAUZ N/A
- Revenue
- TCRX $6,961,000.00
- GAUZ $96,810,000.00
- Revenue This Year
- TCRX $255.18
- GAUZ $23.16
- Revenue Next Year
- TCRX N/A
- GAUZ $40.82
- P/E Ratio
- TCRX N/A
- GAUZ N/A
- Revenue Growth
- TCRX N/A
- GAUZ 7.87
- 52 Week Low
- TCRX $1.02
- GAUZ $4.54
- 52 Week High
- TCRX $6.23
- GAUZ $13.00
- Technical
- Relative Strength Index (RSI)
- TCRX 36.40
- GAUZ 53.75
- Support Level
- TCRX $1.73
- GAUZ $5.37
- Resistance Level
- TCRX $1.96
- GAUZ $6.00
- Average True Range (ATR)
- TCRX 0.11
- GAUZ 0.35
- MACD
- TCRX -0.03
- GAUZ 0.12
- Stochastic Oscillator
- TCRX 0.00
- GAUZ 90.75
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About GAUZ Gauzy Ltd. Ordinary Shares
Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.